FGF23 and hyperphosphatemia: As chronic kidney disease (CKD) progresses, phosphaturic mechanisms such as fibroblast growth factor 23 (FGF23) and parathyroid hormone (PTH) secretion gradually become unable to overcome the continuous supply of phosphate from dietary intake, leading to a positive phosphate balance and hyperphosphatemia [1,2].